PCR – Group B Streptococcus Pathogen Detection

Clinical Services

healthy pregnancy. Side view pregnant woman with big belly advanced pregnancy in hands. Banner copyspace for text. Elegant mother waiting baby

Advanced PCR Testing for Group B Streptococcus: Fast, Accurate, and Reliable Screening

Simplify prenatal screening with a highly sensitive PCR test designed to detect Group B Streptococcus (GBS) quickly and accurately. Our single swab test identifies GBS colonization with greater sensitivity than traditional culture methods, helping providers make informed decisions for intrapartum care and reduce the risk of neonatal infection.

Accurate diagnosis matters. Early identification allows timely intervention that significantly reduces the risk of serious neonatal infection.

Who is most affected?

Newborns

Group B Streptococcus is the leading cause of:

  • Neonatal sepsis
  • Pneumonia
  • Meningitis

Pregnant women

  • Approximately 20% to 30% of pregnant women are carriers
  • Approximately 50% of exposed newborns become colonized during birth without intervention

GBS is common but often silent

Colonization is frequent, but disease risk is situational

Early detection is critical

Early detection prevents severe neonatal complications

Screening changes outcomes

Intrapartum antibiotics can reduce neonatal infection risk by approximately 80%

Partner with Us

Let us show you how advanced molecular diagnostics can transform your respiratory care outcomes.